Company Overview

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. The company offers baking, beverages, dairy, starch, and protein solutions for the food and beverage industry; laundry, dishwashing, and professional cleaning solutions for the household care industry; agriculture solutions, including crop production, and animal health and nutrition solutions; bioyield and biocontrol solutions for crops; and grain and technical processing solutions, as well as bio energy solutions for liquefaction, saccharifaction, fermentation, fiber conversion, and biomass conversion. It also provides textile solutions, such as biopreparation, biopolishing, bleach clean-up, denim abrasion and finishing, and desizing solutions. In addition, the company offers solutions for pulp & paper, including fiber modification, bleach boosting, deposit control, starch modification, and deinking; leather solutions comprising acid bating, area expansion, bating, degreasing, soaking, and unhairing and liming; and water and waste management solutions, which consist of bioaugmentation, biogas, and sludge management. Further, it provides pharmaceutical solutions, including lipases, immobilized lipases, and proteases for biocatalysis, as well as rTrypsin for cell culture; and human health and protein solutions. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.

  • Name

    Novozymes A/S

  • CEO

    -

  • Website

    www.novozymes.com

  • Sector

    Chemicals

  • Year Founded

    1925

Profile

  • Market Cap

    DKK 213.35B

  • EV

    DKK 226.25B

  • Shares Out

    464.62M

  • Revenue

    €3,044.69M

  • Employees

    10,452

Margins

  • Gross

    46.66%

  • EBITDA

    21.92%

  • Operating

    17.24%

  • Pre-Tax

    12.07%

  • Net

    9.29%

  • FCF

    20.74%

Returns (5Yr Avg)

  • ROA

    12.27%

  • ROTA

    28.21%

  • ROE

    23.53%

  • ROCE

    20.47%

  • ROIC

    14.02%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    DKK 469.99

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    €260.8M

  • Net Debt

    €1,728.4M

  • Debt/Equity

    0.18

  • EBIT/Interest

    11.54

Growth (CAGR)

  • Rev 3Yr

    16.85%

  • Rev 5Yr

    9.67%

  • Rev 10Yr

    6.61%

  • Dil EPS 3Yr

    -11.13%

  • Dil EPS 5Yr

    -7.42%

  • Dil EPS 10Yr

    0.01%

  • Rev Fwd 2Yr

    32.3%

  • EBITDA Fwd 2Yr

    47.61%

  • EPS Fwd 2Yr

    6.43%

  • EPS LT Growth Est

    10.4%

Dividends

  • Yield

  • Payout

    107.6%

  • DPS

    €1.1

  • DPS Growth 3Yr

    16.03%

  • DPS Growth 5Yr

    10.4%

  • DPS Growth 10Yr

    12.61%

  • DPS Growth Fwd 2Yr

    28.13%

CPSE:NZYM B